International Journal of Vasculitis

International Journal of Vasculitis

International Journal of Vasculitis – Membership

Open Access & Peer-Reviewed

Submit Manuscript
Open Access • Peer-Reviewed

IJV Membership Program

Advancing the understanding and treatment of vascular inflammatory disorders through collaborative scholarly publishing.

Empowering Vasculitis Research Worldwide

The International Journal of Vasculitis serves as an authoritative platform for disseminating research across all facets of vasculitis and related vascular inflammatory disorders. Our membership program provides rheumatologists, immunologists, vascular medicine specialists, and clinical researchers with comprehensive publishing benefits designed to accelerate the dissemination of vasculitis research findings to the global medical community.

IJV publishes high-quality original research, systematic reviews, and clinical case reports spanning the diagnosis, pathophysiology, epidemiology, and therapeutic management of systemic vasculitides. Whether your research addresses giant cell arteritis, ANCA-associated vasculitis, Takayasu arteritis, or rare small-vessel vasculitides, IJV membership ensures your contributions reach specialists and clinicians worldwide through our open-access model with no subscription barriers.

Our distinguished editorial board comprises internationally recognized vasculitis experts from leading academic medical centers who evaluate manuscripts for scientific rigor, methodological soundness, clinical relevance, and contribution to advancing patient care. Members benefit from expedited manuscript handling, expert subspecialty peer review, and significant publication cost savings that support sustained research productivity throughout their careers.

Membership Benefits

1

Unlimited Manuscript Submissions

Submit unlimited original research articles, systematic reviews, case reports, and clinical studies on vasculitis throughout your membership period with complete APC coverage for regular journal issues.

2

Expert Vasculitis Peer Review

Your manuscripts are evaluated by rheumatologists, immunologists, and vascular medicine specialists who understand the complex diagnostic criteria and treatment paradigms unique to vasculitic disorders.

3

Global Open Access Distribution

Published research reaches vasculitis specialists, rheumatologists, nephrologists, and pulmonologists worldwide through unrestricted open-access distribution without institutional subscription barriers.

4

Professional Recognition Certificate

Receive an official IJV Membership Certificate formally acknowledging your commitment to advancing vasculitis research and contributing to improved patient outcomes globally.

Membership Tiers

Individual Researcher

Clinician-Scientist

Designed for rheumatologists, immunologists, and academic researchers conducting vasculitis studies. Includes unlimited submissions with full APC waivers and 30% discount on special issues.

Duration Standard Member Rate
1 Year $5,400 $2,970
2 Years $6,300 $3,465

Trainee Membership

Fellows & Residents

Supporting rheumatology fellows and clinical immunology trainees building research portfolios. Requires program director recommendation confirming active enrollment.

Duration Standard Trainee Rate
1 Year $3,200 $2,080
2 Years $3,700 $2,405

Institutional Partnership

Academic Centers

Academic rheumatology divisions and vasculitis research centers benefit from comprehensive agreements covering all affiliated investigators and research faculty.

Duration Investment Manuscripts Per Article
1 Year $9,500 20 $475
2 Years $11,500 30 $383

Corporate Partnership

Pharma & Biotech

Pharmaceutical companies developing vasculitis therapeutics gain credibility through peer-reviewed publication of clinical trial data and mechanistic studies.

Tier Publications Standard Partner
Silver 10/year $5,600 $3,640
Gold 15/year $6,500 $4,225

Vasculitis Topics We Publish

Giant Cell Arteritis ANCA-Associated Vasculitis Takayasu Arteritis Polyarteritis Nodosa Kawasaki Disease Behçet Disease Cryoglobulinemic Vasculitis CNS Vasculitis Cutaneous Vasculitis IgA Vasculitis

Frequently Asked Questions

What types of vasculitis research does IJV prioritize?

IJV welcomes research across all vasculitis classifications—large, medium, and small vessel—including diagnostic studies, epidemiological investigations, pathophysiology research, treatment outcomes, and translational studies.

Are case reports on rare vasculitides accepted?

Yes. Given the rarity of many vasculitic syndromes, well-documented case reports contribute significantly. We welcome cases demonstrating unusual presentations or novel therapeutic approaches.

How does institutional membership benefit departments?

Institutional partnerships cover all department members under a single agreement, simplifying grant budgeting and encouraging collaborative publications across investigator teams.

Can pharmaceutical companies publish clinical trial results?

Industry-sponsored research undergoes the same rigorous peer review. Partnership provides discounted fees while maintaining editorial independence and scientific integrity.

What renewal benefits are available?

Members who renew before expiration receive a 10% loyalty discount and may transfer unused publication credits to the new term to accommodate research timelines.

Does IJV publish imaging and biomarker studies?

Yes. We welcome research on PET-CT, MR angiography, ultrasound techniques, ANCA subtype research, cytokine profiling, and novel diagnostic biomarkers for vasculitis.

Are systematic reviews and meta-analyses within scope?

IJV actively encourages systematic reviews and meta-analyses addressing vasculitis diagnosis, treatment efficacy, and patient outcomes. High-quality evidence synthesis plays a critical role in developing treatment guidelines for rare vasculitic conditions.

What support is available for international authors?

IJV serves a global readership and welcomes submissions from researchers worldwide. Our editorial team provides guidance on manuscript preparation, and English language editing support is available to ensure clarity and publication readiness for non-native speakers.

Membership Terms & Policies

Eligibility: To qualify for membership benefits including APC waivers, the member must be listed as author or corresponding author. Trainee membership requires program director recommendation confirming active enrollment in an accredited rheumatology or immunology training program.

Certification: All registered members receive an official IJV Membership Certificate recognizing contributions to vasculitis research and commitment to advancing patient care through open-access publication.

Coverage: Unlimited submissions are covered for regular issues. Members receive 30% discount on APCs for virtual special issues focusing on specific vasculitides or emerging therapies.

Renewal: Early renewal before expiration qualifies for discount and benefit transfer. Late renewals processed at standard rates. We recommend timely renewal to maintain uninterrupted benefits.

Special Issues: IJV periodically publishes virtual special issues focusing on specific vasculitides, emerging biological therapies, or clinical practice guidelines. Members receive priority consideration for special issue contributions and reduced APC rates for accepted manuscripts in these focused collections.

Important Notice: All membership benefits must be utilized within the designated validity period. Unused entitlements expire at term conclusion unless early renewal is completed. Contact our membership team with questions regarding benefit utilization, tier upgrades, or institutional partnership pathways.

Join the Vasculitis Research Community

Contact our dedicated membership team to discuss the optimal publishing plan for your vasculitis research program. We will assess your publication volume, institutional requirements, and research focus to recommend appropriate membership options tailored to your needs.

Apply for Membership View APC Details

Email: [email protected] | Response within 24 business hours